Noch keine Produkte im Warenkorb.

Ihre Vorteile:

versandkostenfreie Lieferung

i.d.R. sofortige Verfügbarkeit
aller Studien u. Marktanalysen

Bezahlung auf Rechnung
oder per Kreditkarte

Bestell- und Beratungshotline

Gerne helfen wir Ihnen kostenfrei bei der Recherche nach Studien und Marktanalysen:

Tel.: +49 (0)221 168 262 42
E-Mail: service[at]marktforschung.de

Aktuelle Meldungen aus dem Ressort Studien / Marktanalysen:

15.07.10 Kooperation im Vertrieb – wer nicht kooperiert, verliert!

Köln - Wer viel Zeit und Geld hat, der wird in der Wirtschaft alles möglichst alleine machen...


28.06.10 Marktstudie Augenoptik: Die Augenoptikbranche stemmt sich erfolgreich gegen die Wirtschaftskrise

Neuwied - Der deutsche Optikmarkt hat sich zum normalen Konsumgütermarkt entwickelt und seinen...


17.06.10 Marktstudie Elektro-Kleingeräte: Branche im Aufwind

Neuwied - 2009 erreichte der Markt für Elektro-Kleingeräte mit einem Plus von 3,3 Prozent auf 3,4...


Benutzer Anmeldung

Geben Sie Ihren Benutzernamen und Ihr Passwort ein, um sich an der Webseite anzumelden:

Werbung:

Regelmäßig Informationen über neue Studien und Spezialangebote im Shop im kostenlosen E-Mail-Abo.

Mehr Infos? Hier klicken.

Hormone / Stoffwechsel



Studien / Marktanalysen aus der Kategorie Hormone / Stoffwechsel

Titel Veröffentl. Preis netto *

Growth Hormone Deficiency (GHD) - Pipeline Analysis and Market Forecasts to 2016

Von: GlobalData
5 / 2010 1.400,00 €
( 2.000,00 $)

Growth Hormone Deficiency (GHD) - Pipeline Analysis and Market Forecasts to 2016

Summary

GlobalData, the industry analysis specialist’s new report, 'Growth Hormone Deficiency (GHD) - Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global growth hormone deficiency market. The report identifies the key trends shaping and driving the global growth hormone defic... more mehr

Cough, Cold and Allergy (hay Fever) Remedies - Vietnam

Von: Euromonitor
5 / 2010 675,00 €

The number of people migrating to large cities like Hanoi, Danang, and Ho Chi Minh City continued to increase during 2009 and urban noise and air pollution is becoming and ever larger problem in Vietnam. Moreover, the population density in large cities such as Ho Chi Minh City is very high, causing traffic jams and high levels of smoke and dirt which are causing throat, lung, and nose related health problems.

Euromonitor Inte... more mehr

Growth Hormone Deficiency Therapy Area Pipeline Report

Von: Life Science Analytics
4 / 2010 1.046,50 €
( 1.495,00 $)

Life Science Analytics', Growth Hormone Deficiency Therapy Area Pipeline Report contains detailed information on the growth hormone deficiency drug pipeline. This report provides insight into the pipeline status of growth hormone deficiency drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Repo... more mehr

Hormone Replacement Therapy Therapy Area Pipeline Report

Von: Life Science Analytics
4 / 2010 1.046,50 €
( 1.495,00 $)

Life Science Analytics', Hormone Replacement Therapy Therapy Area Pipeline Report contains detailed information on the hormone replacement therapy drug pipeline. This report provides insight into the pipeline status of hormone replacement therapy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipelin... more mehr

Hyperthyroidism Therapy Area Pipeline Report

Von: Life Science Analytics
4 / 2010 1.046,50 €
( 1.495,00 $)

Life Science Analytics', Hyperthyroidism Therapy Area Pipeline Report contains detailed information on the hyperthyroidism drug pipeline. This report provides insight into the pipeline status of hyperthyroidism drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real... more mehr

Hypogonadism Therapy Area Pipeline Report

Von: Life Science Analytics
4 / 2010 1.046,50 €
( 1.495,00 $)

Life Science Analytics', Hypogonadism Therapy Area Pipeline Report contains detailed information on the hypogonadism drug pipeline. This report provides insight into the pipeline status of hypogonadism drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail o... more mehr

Commercial Insight: Hormonal Contraceptives - Look beyond oral contraception for a competitive edge

Von: Datamonitor
10 / 2009 10.640,01 €
( 15.200,00 $)

Introduction

Since the 1960s, hormonal contraceptives have been widely used as effective birth control in the developed world. Although they are mainly used to prevent pregnancies, they can be used for treating other conditions such as acne, endometriosis, and polycystic ovarian syndrome. In 2008, the hormonal contraceptives market was worth $6.2 billion across the seven major pharmaceutical countries.

Scope
<... more mehr

Hormonal Contraceptives Market Forecast

Von: Datamonitor
10 / 2009 10.640,01 €
( 15.200,00 $)

Introduction

Since the 1960s, hormonal contraceptives have been widely used as effective birth control in the developed world. Although they are mainly used to prevent pregnancies, they can be used for treating other conditions such as acne, endometriosis, and polycystic ovarian syndrome. In 2008, the hormonal contraceptives market was worth $6.2 billion across the seven major pharmaceutical countries.

Reasons to P... more mehr

Forecast Insight: Attention-Deficit Hyperactivity Disorder - Shire to stay on top despite drug safety fears and generic competition

Von: Datamonitor
7 / 2009 10.640,01 €
( 15.200,00 $)

Introduction

Driven primarily by continued uptake of Shire's market leading ADHD drug, Adderall XR (amphetamine extended release), seven major market ADHD revenues grew strongly at a compound annual growth rate (200408) of 13.5% to reach almost $4.4 billion in 2008. Ongoing uptake of Shire's Vyvanse (lisdexamfetamine), was also a key contributor to market growth between 2007 and 2008.

Scope

*This report... more mehr

Metabolic Endocrinology Growth Hormone Deficiency

Von: Life Science Analytics
4 / 2008 1.046,50 €
( 1.495,00 $)

Life Science Analytics', 'Metabolic Endocrinology Growth Hormone Deficiency ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail... more mehr

Metabolic Endocrinology Hormone Replacement Therapy

Von: Life Science Analytics
4 / 2008 1.046,50 €
( 1.495,00 $)

Life Science Analytics', 'Metabolic Endocrinology Hormone Replacement Therapy ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real deta... more mehr

Metabolic Endocrinology Hypercalcemia

Von: Life Science Analytics
4 / 2008 1.046,50 €
( 1.495,00 $)

Life Science Analytics', 'Metabolic Endocrinology Hypercalcemia ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pip... more mehr

Metabolic Endocrinology Hypocalcemia

Von: Life Science Analytics
4 / 2008 1.046,50 €
( 1.495,00 $)

Life Science Analytics', 'Metabolic Endocrinology Hypocalcemia ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipe... more mehr

Metabolic Endocrinology Hypogonadism

Von: Life Science Analytics
4 / 2008 1.046,50 €
( 1.495,00 $)

Life Science Analytics', 'Metabolic Endocrinology Hypogonadism ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipe... more mehr

Commercial and Pipeline Insight: HRT for Menopausal Symptoms – A new class restores an old market

Von: Datamonitor
4 / 2008 10.640,01 €
( 15.200,00 $)

Introduction
In 2007, the market value of HRT for menopausal symptoms saw its first upturn since the Women’s Health initiative (WHI) study results in 2002; highly publicized findings which linked HRT to cancer and cardiovascular safety risks. The recent growth of the market is due in part to the increasing price of HRT products but can only be sustained by a similar increase in volume sales.

Scope
Analysis of patien... more mehr

*Unser Angebot richtet sich an gewerbliche Kunden, daher sind alle Preise netto ausgewiesen.

In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%).

Der korrekte Gesamtendpreis wird Ihnen nach Angabe Ihrer Rechnungsadresse im weiteren Bestellablauf ausgewiesen.